MELINDA ABBRING: Open Payments
NPI 1790208197 · EAST CHICAGO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,026 in 88 payments from 17 companies in 2025. Trend: 2023 $1,248 · 2024 $1,782 · 2025 $2,026
Food & beverage: $2,026
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $361 |
| Ardelyx, Inc. | 17 | $330 |
| Fresenius USA Marketing, Inc. | 11 | $240 |
| Calliditas Therapeutics US Inc. | 7 | $230 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $171 |
| Otsuka America Pharmaceutical, Inc. | 7 | $155 |
| Travere Therapeutics, Inc. | 4 | $114 |
| AstraZeneca Pharmaceuticals LP | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
Products named: IBSRELA, VELPHORO, TARPEYO, TAVNEOS, Kerendia, KRYSTEXXA, JYNARQUE, JARDIANCE.
Industry payments across IN — which companies pay providers there.
